Determination of progesterone receptor by chemiluminescent enzyme immunoassay

Abstract

A new method of chemiluminescent enzyme immunoassay (CLEIA) was developed and the standard curve and regression equation for determination of progesterone receptor (PR) made. The luminosity of tissue samples was tested and PR level was calculated by the regression equation. Correlation analysis revealed that there was a linear relationship between different concentrations of the standard PR samples and the corresponding values of luminosity: Y=3748+463.77X, γ=0.9958. The values of the luminosity in 38 cases of tumor tissues were determined with the highest being 267.32 fmol/mg, the lowest 3.69 fmol/mg and the mean 78.53 fmol/mg. The new method of CLEIA was a stable, creditable, specific and sensitive assay for determination of PR.

Keywords

progesterone receptor / chemiluminescent enzyme immunoassay

References

[1] CaoY, SmithW C, BowsherR R. A sensitive chemiluminescent enzyme immunoassay for the bioanalysis of carboxyl—terminal B—chain analogues of human insulin. J Pharm Biomed Anal, 2001, 26(1): 52-52

[2] WilliamT, CreasmanW T. Prognostic significance of hormone receptors in endometrial cancer. Cancer, 1993, 71: 1467-1467

[3] SauerbreiW, HubnerK, SchmoerC. Validation of existing and development of new prognostic classification schemes in node negative breast cancer. Breast Cancer Res Treat, 1997, 42(2): 146-146

[4] PertschukL P, BeddoeA M, GorelicL S. Immunocytochemical assay of estrogen receptors in endometrial carcinoma with monoclonal antibodies. Comparison with biochemical assay. Cancer, 1986, 57(5): 1000-1000